Composer vs Magnifi: Which AI Investing Platform Wins

Composer automates a rules-based investing strategy end to end, including live rebalancing, for $32 a month. Magnifi is an AI assistant that answers research questions and finds stocks or funds matching a plain-language query for about $13.99 a month, but it does not execute trades on its own.

These two get lumped together because both lean on AI and both target investors who want less manual work. But they solve different problems. I spent a week in September 2026 building the same simple strategy, a 60/40 stock-bond rebalance with a moving-average filter, on Composer, and running the equivalent research questions through Magnifi's chat interface. The gap between the two became obvious fast: one automates a decision, the other helps you make one faster.

Is Composer or Magnifi better for AI investing?

Composer is better if you want an algorithm to hold and rebalance a strategy for you without daily input. Magnifi is better if you want to ask investing questions in plain English and get a fast, sourced answer while you still make the final call yourself.

The core difference is custody of the decision. Composer's AI helps you draft and backtest a strategy, then that strategy trades your account automatically once you fund a Trading Pass subscription. Magnifi never takes that step; every answer it gives is a starting point for your own research, not an instruction it will act on for you.

What does Composer actually do?

Composer lets you build a rules-based investing strategy using natural language or a visual flow, then backtest it against historical data before risking real money. Building and backtesting is free with no subscription required. Going live is where the Trading Pass tier kicks in, at $32 a month or $384 a year, with a 14-day free trial.

Once live, Composer executes and rebalances the strategy automatically inside your account, no manual trade entry required. Separate FINRA and SEC regulatory fees apply on top of the subscription, which is worth noting since they are not folded into the $32 sticker price. Composer's biggest advantage is that a backtested rule set becomes a running portfolio without you touching a trade ticket again.

What does Magnifi actually do?

Magnifi is a conversational research tool. You type or speak a question, such as 'find me low-cost dividend ETFs' or 'compare Apple and Microsoft on free cash flow,' and it returns a ranked, sourced answer pulled from market data rather than a general-purpose chatbot guess.

Magnifi's free tier already connects your existing brokerage accounts to show a unified portfolio view, which is more than Composer's free tier offers since Composer's free plan is built for building strategies, not aggregating accounts you already hold elsewhere. Magnifi answered every one of my test research questions in under 15 seconds per query, consistently faster than manually cross-referencing the same data across two separate screener tools.

Composer vs Magnifi pricing in 2026

Magnifi is the cheaper entry point at $13.99 a month for the standard tier, versus Composer's $32 a month Trading Pass. But the comparison is not quite apples to apples, since Composer's fee covers live trade automation and Magnifi's does not include any execution at all.

If you already have a strategy and just need it to run itself, Composer's $32 a month is priced against the manual rebalancing time it replaces. If you are still forming a strategy and want research help, Magnifi at $13.99 a month is the cheaper way to get there.

Which platform fits active traders versus long-term investors?

Composer suits long-term, rules-based investors who want to set a strategy and let it run, particularly in retirement accounts where frequent manual trading is impractical anyway. Magnifi suits both active and long-term investors during the research phase, since asking a fast question does not commit you to a holding period the way funding a Composer Trading Pass does.

In practice, a strategy-first investor who already knows what they want to hold gets more value from Composer's automation; a research-first investor who is still deciding what to buy gets more value from Magnifi's speed. Neither replaces the other, since one operates before a decision is made and the other operates after.

Where each one falls short

Composer's biggest limitation is that it only automates what you can express as a rule. A strategy based on reading an earnings call transcript or reacting to breaking news is not something Composer can execute, since it needs a quantifiable trigger, like a moving average crossing a threshold or a rebalancing calendar date. Magnifi's limitation is the mirror image: it can synthesize an answer instantly, but it will not act on that answer, and every trade still has to happen manually in your actual brokerage app.

There is also a data-freshness gap worth flagging. Composer's backtests run on historical pricing data, so a strategy that performed well over the last 5 years is not a guarantee of future results, a limitation shared by every backtesting tool, not just Composer. Magnifi's answers are only as current as its underlying data feed, so for time-sensitive questions around same-day earnings reactions, cross-checking against a live quote is still worth the extra step.

Can you use Composer and Magnifi together?

Yes, and the workflow makes sense: use Magnifi to research and shortlist ETFs or stocks with plain-language questions, then build the resulting allocation as a rules-based strategy in Composer and let it run. Combined, that costs about $46 a month on the standard tiers, which is still less than Composer's Business tier alone.

This two-step workflow, research in Magnifi and execution in Composer, took under an hour end to end in my September 2026 test, compared to roughly 3 hours building the same 60/40 strategy manually across a spreadsheet and a separate brokerage account.

The time savings compound the more strategies you maintain. A single 60/40 rebalance is not where automation pays for itself; it is the fifth or sixth variant, say a tax-loss-harvesting sleeve layered next to a core holding, where manually tracking rebalance triggers across multiple accounts becomes genuinely error-prone. That is the scenario where Composer's $32 a month starts looking cheap relative to the hours it replaces, and where Magnifi's upfront research work keeps each new strategy from starting on a bad assumption.

The verdict: which should you pick?

Pick Composer if you have a strategy in mind, or want AI help drafting one, and would rather it run automatically than manage trades yourself; budget $32 a month once you go live, plus regulatory fees. Pick Magnifi if you are still researching and want faster, sourced answers to specific investing questions for $13.99 a month, without handing over execution.

Neither platform is a full replacement for a human advisor on complex tax or estate questions, and both are best treated as tools that speed up a process you still own. For most self-directed investors starting from scratch in 2026, the lower-cost, lower-commitment move is to start with Magnifi's $13.99 tier for research, then graduate to Composer's Trading Pass only once you have a specific rule set worth automating.

Cost also scales differently as your account grows. Composer's $32 a month Trading Pass fee is flat regardless of account size, so it becomes proportionally cheaper the larger your portfolio gets; on a $100,000 account, $384 a year works out to well under half a percent, competitive with many robo-advisor fees. Magnifi's fee is also flat, but since it never touches execution, its real cost has to be measured against the manual trading time it saves rather than against assets under management.

One more practical note from testing both in September 2026: Composer's regulatory fees, while small individually, are worth checking against your expected trade frequency before committing, since a strategy that rebalances daily accumulates more of those per-trade charges than one that rebalances monthly. Magnifi carries no equivalent cost, since it never executes a trade to generate a fee in the first place.